Weight gain following treatment of hyperthyroidism
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
OBJECTIVE Patients frequently express concern that treating hyperthyroidism will lead to excessive weight gain. This study aimed to determine the extent of, and risk factors for, weight gain in an unselected group of hyperthyroid patients. DESIGN and SUBJECTS We investigated 162 consecutive hyperthyroid patients followed for at least 6 months. Height, weight, clinical features, biochemistry and management were recorded at each clinic visit. RESULTS Documented weight gain was 5·42 ± 0·46 kg (mean ± SE) and increase in BMI was 8·49 ± 0·71%, over a mean 24·2 ± 1·6 months. Pre‐existing obesity, Graves' disease causing hyperthyroidism, weight loss before presentation and length of follow‐up each independently predicted weight gain. Patients treated with thionamides or radioiodine gained a similar amount of weight (thionamides, n = 87, 5·16 ± 0·63 kg vs. radioiodine, n = 62, 4·75 ± 0·57 kg, P = 0·645), but patients who underwent thyroidectomy (n = 13) gained more weight (10·27 ± 2·56 kg vs. others, P = 0·007). Development of hypothyroidism (even transiently) was associated with weight gain (never hypothyroid, n = 102, 4·57 ± 0·52 kg, transiently hypothyroid, n = 29, 5·37 ± 0·85 kg, on T4, n = 31, 8·06 ± 1·42 kg, P = 0·014). This difference remained after correcting for length of follow‐up. In the whole cohort, weight increased by 3·95 ± 0·40 kg at 1 year (n = 144) to 9·91 ± 1·62 kg after 4 years (n = 27) (P = 0·008), representing a mean weight gain of 3·66 ± 0·44 kg/year. CONCLUSION We have demonstrated marked weight gain after treatment of hyperthyroidism. Pre‐existing obesity, a diagnosis of Graves' disease and prior weight loss independently predicted weight gain and weight continued to rise with time. Patients who became hypothyroid, despite T4 replacement, gained most weight.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bunevičius, R., Kažanavičius, G., Žalinkevičius, R., & Prange, A. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400603 · Cited by 482 · cited 1×
“It has been suggested that combination treatment with triiodothyronine may achieve better resolution of symptoms (Bunevicius et al., 1999), and could also improve outcome of weight changes in both primary and secondary hypothyroidism.”
BackgroundZimmermann‐Belsing, T., Dreyer, M., Juul Holst, J., & Feldt‐Rasmussen, U. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00627.x · Cited by 49
Cited by
Saravanan, P., Chau, W. ‐., Roberts, N., Vedhara, K., Greenwood, R., & Dayan, C. M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01654.x · Cited by 514
Management of Graves Disease: A Review
Burch, H. B., & Cooper, D. S. (2015) · JAMA · doi:10.1001/jama.2015.16535 · Cited by 332
Fox, C. S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.6.587 · Cited by 303
Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis
Wiersinga, W. M., Poppe, K. G., & Effraimidis, G. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00005-0 · Cited by 254
Santini, F., Marzullo, P., Rotondi, M., Ceccarini, G., Pagano, L., Ippolito, S., Chiovato, L., & Biondi, B. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0067 · Cited by 240
Metadata
- Authors
- Dale, J., Daykin, J., Holder, R., Sheppard, M. C., & Franklyn, J. A.
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2001-08
- Volume
- 55
- Issue
- 2
- Pages
- 233-239
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W2067984291
- Cited by
- 135
- References
- 2
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.